Related Experiment Video
Updated: May 21, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
The tape measure protein of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 has an active muramidase domain
Lorena Rodríguez-Rubio1, Dolores Gutiérrez, Beatriz Martínez
1Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Department of Technology and Biotechnology of Dairy Products, Asturias, Spain.
Abstract:
Tailed double-stranded DNA (dsDNA) bacteriophages frequently harbor structural proteins displaying peptidoglycan hydrolytic activities. The tape measure protein from Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 has a lysozyme-like and a peptidase_M23 domain. This report shows that the lysozyme-like domain (TG1) has muramidase activity and exhibits in vitro lytic activity against live S. aureus cells, an activity that could eventually find use in the treatment of infections.
Insights
Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35's tape measure protein contains a lysozyme-like domain (TG1) with muramidase activity. This domain shows in vitro lytic activity against live Staphylococcus aureus cells, offering potential for infection treatment.
Area of Science:
- Microbiology
- Virology
- Biochemistry
Background:
- Tailed double-stranded DNA (dsDNA) bacteriophages often possess structural proteins with peptidoglycan hydrolytic functions.
- The tape measure protein of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 includes both a lysozyme-like and a peptidase_M23 domain.
Purpose of the Study:
- To investigate the enzymatic activity of the lysozyme-like domain (TG1) from Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35.
- To assess the lytic potential of the TG1 domain against live Staphylococcus aureus cells.
Main Methods:
- Characterization of the lysozyme-like domain (TG1) of the tape measure protein.
- In vitro assays to determine muramidase activity.
- Testing lytic activity against live Staphylococcus aureus bacterial cells.
Main Results:
- The lysozyme-like domain (TG1) was confirmed to possess muramidase activity.
- TG1 demonstrated in vitro lytic activity against live Staphylococcus aureus cells.
Conclusions:
- The lysozyme-like domain (TG1) of the Staphylococcus aureus tape measure protein exhibits enzymatic activity.
- This domain's lytic properties suggest potential applications in treating bacterial infections.
Related Concept Videos
DNA Bacteriophages
Regulation of Bacterial Virulence
Viral Replication: Lytic Cycle

